SCHEMBL1432941

SCHEMBL1432941

COc1ccc(Cc2n[nH]c3nnccc23)c(F)c1Oc1cc(Cl)cc(C#N)c1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.50
KCNH2 Q12809 4/20 0.45
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 1/20 0.44
CYP2D6 P10635 1/20 0.35
SLC22A12 Q96S37 2/20 0.34
SLC6A4 P31645 1/20 0.34
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
PDE5A O76074 6/20 0.32
NR3C1 P04150 1/20 0.31
NR3C2 P08235 1/20 0.31
NTRK1 P04629 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1344351 0.90 CYP3A4 (0.53) CYP3A4KCNH2CYP2C9CYP2C19CYP2D6
SCHEMBL1350197 0.90 CYP3A4 (0.52) CYP3A4KCNH2CYP2C9CYP2C19CYP2D6
SCHEMBL1344586 0.88 CYP3A4 (0.49) CYP3A4KCNH2CYP2C9CYP2C19CYP2D6
SCHEMBL1344333 0.87 CYP3A4 (0.48) CYP3A4KCNH2CYP2C9CYP2C19CYP2D6
SCHEMBL1341414 0.86 CYP3A4 (0.50) CYP3A4KCNH2CYP2C9CYP2C19CYP2D6
SCHEMBL1343511 0.85 CYP3A4 (0.47) CYP3A4KCNH2CYP2C9CYP2C19CYP2D6
SCHEMBL1350118 0.85 CYP3A4 (0.52) CYP3A4KCNH2CYP2C9CYP2C19CYP2D6
SCHEMBL1344603 0.83 KCNH2 (0.47) CYP3A4KCNH2CYP2C9CYP2C19
SCHEMBL1344607 0.83 CYP3A4 (0.53) CYP3A4KCNH2CYP2C9CYP2C19
SCHEMBL4554159 0.82 KCNH2 (0.45) CYP3A4KCNH2CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2057125-B1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2011-03-30 EP claimed
EP-2057125-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS F. Hoffmann-Roche AG (CH) 2009-05-13 EP claimed
WO-2008019968-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2008-02-21 WO claimed
EP-2057125-B1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2011-03-30 EP disclosed